MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.

200751 citationsJournal Article

Authors

Michele Quaranta

Antonella Daniele · Istituti di Ricovero e Cura a Carattere Scientifico

M. Coviello

Maria Teresa Venneri

Ines Abbate · Istituti di Ricovero e Cura a Carattere Scientifico

Maria Elena Caringella

Silvia Di Tardo · League Against Cancer

Rosa Divella · Istituti di Ricovero e Cura a Carattere Scientifico

Paolo Trerotoli

Abstract

The present study failed to demonstrate any association between serum levels of MMPs, VEGF and CA 15.3 and well-known clinicopathological characteristics of breast carcinoma, while demonstrating the prognostic value of CA 15.3 and pro MMP-9 in the follow-up of breast cancer patients.

Topics & Keywords

Protease and Inhibitor Mechanisms S100 Proteins and Annexins Peptidase Inhibition and Analysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 27, Issue 5B, pp. 3593-600

Field-Weighted Citation Impact: 1.06